Daniel M. Bendheim, Executive VP, Corporate Strategy at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 4,176 shares at $40.01 ($167K) on 2017-08-17, disclosed to the SEC on 2017-08-21.
Open-market sale of $167k PAHC by Executive VP, Corporate Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PAHC | SELL | 2019-01-30 | $153K | — | Filing → |
| PAHC | SELL | 2019-01-24 | $60K | — | Filing → |
| PAHC | SELL | 2019-01-24 | $237K | — | Filing → |